<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=875423625897521&amp;ev=PageView&amp;noscript=1">

Sensing Savvy

Cardiovascular Disease in ESRD Patients

Posted by Susan Eymann, MS on Sep 23, 2019

(Gleaned from the 2018 USRDS Annual Data Report: Volume II: Chapter 8)

Patients with end-stage renal disease (ESRD) are among the highest risk populations for cardiovascular diseases (CVDs)—a major cause of death in ESRD patients. The kidney news-2relationship between kidney disease and acute myocardial infarction (AMI), coronary artery disease (CAD), heart failure (HF), and sudden death/cardiac arrhythmias is complex and bi-directional. ESRD often complicates disease management of CVD, influencing both medical and procedural options, thereby adversely affecting a patient’s prognosis.

  • Cardiovascular disease is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease the most common condition, exceeding 50% in HD patients age 65 and older.
  • Heart failure is also common in ESRD patients.
  • Older ESRD patients have a higher prevalence of cardiovascular conditions than younger patients, whether they were receiving HD or PD.
  • Even relatively young ESRD patients—those ages 22-44 and 45-64 —are likely to suffer from cardiovascular disease.
  • Cardiovascular diseases increase short- and long-term mortality for ESRD patients.
  • Only about two-thirds of dialysis or transplant patients with acute myocardial infarction (AMI) received beta-blocker medication. Similarly, among ESRD patients with heart failure, fewer than half received angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). Although many ESRD patients with atrial fibrillation (AF) are at elevated risk of stroke, only about one-third of dialysis patients with AF were treated with warfarin.
  • Peritoneal dialysis patients had a lower burden of certain cardiovascular conditions, including coronary artery disease, heart failure, and peripheral artery disease, as compared to their HD counterparts.
    Non-invasive cardiac function assessment

Topics: Hemodialysis

Healthcare Insights to Improve Results

Sensing Savvy provides you with the  information you need to stay up to date on the latest clinical news and trends, techniques, products and more. Start advancing your outcomes. Subscribe today.

Get Articles and Insights by Email

Recent Posts

StackAdapt Pixel